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Table 1 Balance of possible confounding factors between groups. BIS, bispectral index; MAC, minimum alveolar concentration;
standard deviation.
BIS 50

MAP (mm Hg), mean (SD)
Inotrope used, n (%)
Ketamine, n (%)
Dexmedetomidine, n (%)
Age-adjusted MAC, mean (SD)

SD,

BIS 35

Delirium N¼47

No delirium N¼206

Delirium N¼74

No delirium N¼188

83.4 (15.8)
32 (68)
2 (4)
3 (6)
0.66 (0.19)

85 (22.3)
101 (49)
10 (5)
7 (3)
0.73 (0.18)

81.0 (9.4)
52 (71)
5 (7)
0 (0)
1.01 (0.30)

80.9 (15.6)
135 (72)
4 (2)
14 (7)
0.96 (0.27)

been significant reported separation between groups in
depth of anaesthesia.3
We look forward to the publication of further randomised
studies that test the possible causative mechanisms mentioned,
so that anaesthetists can be guided by sound evidence. Meanwhile, we maintain that our study was balanced.
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EditordThoracotomy incisions used to gain access to the
thoracic organs, lead to chronic pain in an estimated 25e60%
of cases.1 Considerable nerve damage is common in
thoracotomy, as rib retractors used in this operation block
conduction of intercostal nerves near the incision by

50e100%.2 Video-assisted thoracoscopic surgery (VATS), an
alternative to conventional thoracotomy, involves less nerve
damage owing to smaller incisions and no rib retraction, and
is associated with increased tolerability for patients and
better patient outcomes.3 However, even with VATS many
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patients still suffer from moderate to severe postoperative
pain.3
Sensitivity to acute postoperative pain is amongst the most
significant risk factors for development of chronic postsurgical
pain.4,5 However, the extent of neuropathic pain experienced
after surgery is highly variable between individuals, even
when the underlying nerve injury is assessed as identical.6
There are currently no reliable methods available to accurately predict sensitivity to acute postoperative pain or the
likelihood of it developing into chronic pain,7 thus hindering
development of early intervention and prevention strategies.
One candidate biomarker for predicting pain sensitivity is
peak alpha frequency (PAF). PAF is the frequency with the
greatest power in the 8e14 Hz bandwidth, measured using
EEG. PAF is a stable heritable trait within individuals.8
In healthy participants, before the induction of a prolonged
(but temporary) painful experience, PAF is negatively related
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to their pain ratings.9,10 Furman and colleagues9 found a
relationship between PAF and experimental pain sensitivity,
and that PAF can predict pain sensitivity for multiple pain
models even months later.10 These findings suggest that PAF
can serve as a reliable biomarker for pain ratings, and could be
a powerful clinical tool.
In this pilot study, we directly investigated if PAF can be
used as a clinical tool to stratify pain-sensitive patients.
Specifically, we investigated whether preoperative PAF,
measured using cEEGrids (TMSi, Oldenzaal, The Netherlands;
https://ceegrid.com), correlated with postoperative pain
severity in 16 patients (6 female; mean [standard deviation]
age¼67.5 [4.4] yr; range, 59e73 yr) undergoing surgery for lung
cancer. Written consent, PAF, and baseline pain were
collected up to 4 weeks before surgery (8.6 [6.4] days) during
standard preoperative assessments. Within 72 h after surgery, patients were asked to report their present, average, and
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Fig 1. The receiver operating characteristic curve of preoperative peak alpha frequency (PAF) in (a) classifying severe (>7/10) postoperative
pain, and (b) classifying individuals reporting severe ‘average pain experienced in the last 24 h’ (c). The frequency spectrum of patients
(n¼14) median split according to their worst postoperative pain, showing that the high pain group had slower PAF. AUC, area under the
curve; CI, confidence interval; ROC, receiver operative characteristic.
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worst pain in the past 24 h (see Supplementary Material A for
detailed methods).
Use of EEG in a clinical setting is not novel. However,
conventional full-cap EEG has several disadvantages: setup
is time-consuming and patients are required to wash their
hair, inconveniencing patients and clinical staff. To
circumvent these issues, we used cEEGrids, newly developed
around the ear electrodes. Assessment of PAF using cEEGrids
was fast, comfortable for patients, and technically feasible
(Supplementary Material B).
We found that preoperative PAF was negatively correlated
with present (n¼16), average and worst (n¼14) postoperative
pain (all P<0.02; Supplementary Material C). Postoperative
complications prevented assessment of average and worst
postoperative pain for two patients. Postoperative pain was
not associated with preoperative pain (Supplementary
Material D), operation type (13 VATS, 3 thoracotomy), analgesic type (10 paravertebral catheter, 5 patient-controlled
analgesia [PCA], 1 epidural catheter), age, or sex
(Supplementary Material E).
For classification, we used the receiver operative characteristic (ROC) curve to assess the sensitivity and specificity of preoperative PAF in identifying patients reporting severe ‘worst’
postoperative pain (Fig. 1a). The area under the curve (AUC) was
0.939 (standard error [SE]¼0.077; P<0.001; 95% confidence interval [CI], 0.80e1.07). A PAF of <9 Hz offered a sensitivity (i.e. ability
to correctly identify a patient reporting severe pain) of 1.0 and a
specificity (i.e. ability to correctly identify a patient not reporting
severe pain) of 0.86. When classifying individuals reporting severe ‘average’ postoperative pain (Fig. 1b), the AUC was 0.923
(SE¼0.074; P<0.001; 95% CI, 0.778e1.07). A PAF of <9 Hz offered a
sensitivity of 1.0 and a specificity of 0.5. When classifying patients experiencing severe ‘present’ pain, sensitivity was 0.65
and specificity was 0.54.
We found that a median split of worst postoperative pain
ratings revealed significant differences in PAF across patients
(Fig. 1c). A ManneWhitney U-test showed that preoperative PAF
was significantly faster (W¼74, P¼0.004) for those with lower
worst postoperative pain (median, 9.25 Hz; range, 8.65e9.41 Hz)
compared with those with higher worst postoperative pain
(median, 8.62 Hz; range, 7.81e8.82 Hz). These results suggest that
PAF could be a useful clinical tool for identifying patients likely to
experience severe acute pain after thoracic surgery. Follow-up
data were also collected for some participants at 6 weeks and
~15 months postoperatively (Supplementary Material F).
Although our work remains to be replicated in a larger population of patients, if PAF is shown to be a sensitive and specific
biomarker of pain sensitivity, it would allow surgeons and
anaesthetists to identify patients at risk of severe acute postoperative pain preoperatively. This identification would enable
provision of targeted interventions with pre-emptive analgesic
strategies for chronic postoperative pain (e.g. small incision,
regional analgesic nerve block, or neuropathic pain medications).
This study also has implications for treatment of painsensitive individuals undergoing other types of surgeries (e.g.
cardiac) or interventions (e.g. chemotherapy). Establishing
biomarkers to predict development of acute and chronic
postoperative pain could move the focus away from pain

treatment and towards pain prevention; preoperative PAF is a
prime candidate that warrants further investigation.
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Appendix A. Supplementary data
Supplementary data to this article can be found online at
https://doi.org/10.1016/j.bja.2022.03.006.
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